Massachusetts College of Pharmacy and Health Sciences
Final Pearls and Takeaways for Testing and Managing CKD
Experts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
AI CKD Test Clinical Implementation and Provider Pearls
Robert Busch, MD, provides his approach on implementing artificial intelligence (AI) testing for chronic kidney disease and offers success stories of this testing and treatment approach.
Catching CKD Early: Utilizing AI and its Clinical Significance
Experts discuss a new artificial intelligence (AI) tool for earlier staging and management of chronic kidney disease (CKD). They also discuss several studies where this tool was utilized and its overall clinical significance.
Emerging Treatments and Preventative Care for CKD
Dhiren Patel, PharmD, and Robert Busch, MD, discuss emerging technologies to test and treat patients with chronic kidney disease (CKD) and why these treatments are currently being underutilized.
Identifying and Managing CKD With Other Comorbid Conditions
Experts highlight considerations for patients with chronic kidney disease and other comorbid conditions, particularly diabetes, in terms of screening and preventative care.
Filling the Gap: Testing to Identify Early-Stage CKD
Experts discuss key challenges in testing and diagnosing a patient with chronic kidney disease, especially for those who are asymptomatic. In addition, they highlight new screening approaches to accurately identify these patients.
Identifying CKD: Screening and Guideline Implementation
Robert Busch, MD, discusses common screening methods to detect chronic kidney disease (CKD) and how he utilizes the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines in his practice.
Overview of Chronic Kidney Disease (CKD) and Impact on Patients
Dhiren Patel, PharmD, and Robert Busch, MD, present an overview of chronic kidney disease (CKD) and how it may impact a patient.
2 Clarke Drive Cranbury, NJ 08512